| Previous Close | 3.050 |
| Open | 3.090 |
| Bid | 3.110 x 3200 |
| Ask | 3.120 x 600 |
| Day's Range | 3.050 - 3.140 |
| 52 Week Range | 0.680 - 3.160 |
| Volume | 380,900 |
| Avg. Volume | 912,066 |
| Market Cap | 262.12M |
| Beta | 1.65 |
| PE Ratio (TTM) | -14.55 |
| EPS (TTM) | -0.21 |
| Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.56 |
- Accesswire•9 days ago
Today's Research Reports on Trending Tickers: Nektar Therapeutics and Catalyst Pharmaceuticals Inc.
NEW YORK, NY / ACCESSWIRE / July 12, 2017 / After a dismal 2016, the Biotech Industry has rallied back in 2017 as regulation fears have subsided. The iShares NASDAQ Biotechnology Index ETF and the SPDR ...
- GlobeNewswire•25 days ago
Catalyst Pharmaceuticals Joins Russell 3000 Index
CORAL GABLES, Fla., June 26, 2017-- Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular ...
- Investopedia•last month
Three Junior Biotechs Ready to Run
Junior biotechs are attracting strong speculative interest that could offer outstanding returns for traders with well-honed risk management skills.
